AOD-9604
AOD-9604 risk profile, scheduling, and guidance for claims professionals and care workers .
AOD-9604 is classified as Low risk (1 risk points) by AllMeds. Modified HGH fragment for fat metabolism. Some clinical trial data. AUST-L listed as complementary medicine in some forms.
Key Takeaways
- Risk level: Low (1 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | Not PBS listed |
Risk Profile
Modified HGH fragment for fat metabolism. Some clinical trial data. AUST-L listed as complementary medicine in some forms.
Regulatory and Compliance Guidance
When AOD-9604 appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Clinical Evidence
- AOD9604 Phase IIb Clinical Trial for Obesity (2011)
Phase IIb trial by Metabolic Pharmaceuticals. Failed to show significant weight loss vs placebo. Development discontinued for obesity indication.
Published trial but drug failed its primary endpoint
- AUST-L listing for AOD-9604 as complementary medicine ingredient (2023)
AOD-9604 has been listed on AUST-L in some topical/oral complementary medicine formulations. Not registered as a therapeutic good for injection.
AUST-L listing = lower evidence bar than ARTG registration
Need to assess this medication across your caseload?
Run a full risk assessment including AOD-9604 interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.